"Mild is not always so mild," said Dr. William Schaffer, a professor of medicine at Vanderbilt University and medical director of the National Foundation for Infectious Disease. He warns that ...

The researchers found "a staggering" 90% of people living with long COVID only had a mild illness to start — but people who were hospitalized were more likely to develop the lasting symptoms.

How Covid infection affects the brain: Even mild cases of Covid-19 are associated with subtle tissue damage and accelerated losses in brain volume, study shows.

Paxlovid is most helpful for people with mild COVID symptoms who are at high risk of developing severe disease. Because it works by stopping the virus making copies of itself, to be effective, it ...

Patients with 'blinding' headaches known as Idiopathic Intercranial Hypertension (IIH) could be treated with a GLP-1RA peptide used for type 2 diabetes, a new phase 2 trial has found.